NAM logo

  • site map
  • contact
  • advanced search

  • home
  • news
  • treatment & care
  • hiv worldwide
  • living with hiv
  • preventing hiv
  • organisations
  • hiv basics
  • about us

Aidsmap

patient information


  • Russian
  • Français
  • Português
  • Español

YOU ARE HERE:
  • > Patient Information
  • >> Booklets
  • >>> Anti-HIV Drugs
  • >>>> Summary
Summary
print this page printer friendly version send to friend send to friend glossary glossary comment comment pdf version pdf version
   Last updated: 07.06.05
previous
 
  • Anti-HIV drugs prevent HIV from damaging your immune system, and so prevent ill health and prolong survival.


  • The best time to begin anti-HIV drugs is not known. Decisions are guided by the CD4 count and viral load. It is currently recommended that treatment starts before the CD4 count falls below 200.


  • Combinations of at least three anti-HIV drugs provide the best chance of reducing the amount of HIV in your blood to very low levels.



  • Taking your anti-HIV drugs as prescribed is extremely important, as this will prolong the benefit you will get from them, and reduce the risk of resistance to the drugs developing.


  • Tell a member of your HIV care team (doctor, nurse or pharmacist) if you are having problems with your anti-HIV drugs. Make sure that they know about any other medicines you are taking (including those bought from a chemist, herbal preparations and recreational drugs).


  • Five classes of antiretroviral drugs are now available in the UK.





 

subscribe to aidsmap email bulletins

 
previous


Booklets
Anti-HIV Drugs
  • Introduction
  • HIV and anti-HIV drugs
  • Types of antiretroviral drugs
  • Where antiretrovirals block HIV
  • Nucleoside analogue reverse transcriptase inhibitors (NRTIs)
  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
  • Nucleotide analogue reverse transcriptase inhibitors (NtRTIs)
  • Protease inhibitors (PIs)
  • Fusion inhibitors
  • Other drugs
  • Summary


Support our work today



  • contact
  • email update
  • disclaimer
  • copyright